Primary laryngospasm in a patient with Parkinson's disease: Treatment with CPAP via minitracheostomy following intubation
β Scribed by B. F. Fikkers; D. F. Zandstra
- Publisher
- Springer
- Year
- 1995
- Tongue
- English
- Weight
- 252 KB
- Volume
- 21
- Category
- Article
- ISSN
- 1432-1238
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
FIG. 1. SPECT study performed with technetium-99m-ethyl cysteinate dimer. The images were analyzed with an easy Z-score (eZIS) imaging system. The first eZIS images on SPECT showed increased rCBF in the right medial temporal lobe (A). The second eZIS images on SPECT revealed that the increased rCBF
## Abstract Due to its low profile for extrapyramidal sideβeffects, quetiapine has become an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease (PD). We describe the case of a patient with PD who developed severe akathisia, a common complication
## Abstract A new formulation of a sublingual tablet with 10 mg apomorphine was examined in 13 patients with Parkinson's disease. Vitamin C (250 mg) was added sublingually to lower the salivary pH. Four patients received sublingual apomorphine and nine received sublingual apomorphine as well as vit